← Back to Search

Combined for Attention Deficit Hyperactivity Disorder (ADHD)

N/A
Waitlist Available
Led By Amori Y Mikami, PhD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the first day of the treatment and the last day of the treatment (two weeks later)
Awards & highlights

Study Summary

Children with Attention-Deficit/Hyperactivity Disorder (ADHD) comprise about 5-10% of the elementary school-age population. One place where children with ADHD have great difficulty is in being accepted by peers and in making friends. It has unfortunately been very difficult for the field to find good treatments for peer relationship problems for this population. Even when children with ADHD do improve their behavior, it is common that peers do not seem to like the child with ADHD any better. This may happen because children often have negative reputations with their classmates that are hard to change. That is, once a class of children get the impression that one child is disliked or the social outcast, even if that child's ADHD symptoms get better, the peer group may not notice any of these improvements. It is hypothesized that the elementary school teacher may be able to help peers notice positive behavior changes in children with ADHD when they do occur. This clinical trial will design and pilot-test an intervention that would train teachers in classroom practices to reduce the peer rejection of students with ADHD. The pilot test will be conducted in a summer program created to be similar to a regular school classroom in structure. If the treatment seems to succeed in the summer program, then it will be tried in regular classrooms in a future study.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the first day of the treatment and the last day of the treatment (two weeks later)
This trial's timeline: 3 weeks for screening, Varies for treatment, and the first day of the treatment and the last day of the treatment (two weeks later) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Child Peer Relationships
Secondary outcome measures
Child Behavior Problems

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CombinedExperimental Treatment2 Interventions
This represents a combination of the tolerance training and behavioral management interventions together.
Group II: Behavioral managementActive Control1 Intervention
This represents the behavioral contingency management intervention only.

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
753 Previous Clinical Trials
1,244,929 Total Patients Enrolled
2 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
514 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Amori Y Mikami, PhDPrincipal InvestigatorUniversity of Virginia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025